H
Herantis Pharma Oyj
OMXH:HRTIS
Herantis Pharma Oyj
OMXH:HRTIS
Price:
1.296
EUR
-0.15%
Market Cap:
€34.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Herantis Pharma Oyj
OMXH:HRTIS
|
FI |
|
C
|
CMO PCL
SET:CMO
|
TH |
|
V
|
Vincenzo Zucchi SpA
MIL:ZUC
|
IT |
|
D
|
Danske Bank A/S
DUS:DSN
|
DK |
|
H
|
Hextar Technologies Solutions Bhd
KLSE:HEXTECH
|
MY |
|
B
|
Bavarian Nordic A/S
F:BV3
|
DK |
|
Reti SpA
MIL:RETI
|
IT |
|
L
|
Lease IT PCL
SET:LIT
|
TH |
|
M
|
Maybulk Bhd
KLSE:MAYBULK
|
MY |
|
US Critical Metals Corp
F:0IU
|
CA |
|
B
|
Blender Financial Technologies Ltd
TASE:BLND
|
IL |
|
Caisse regionale de Credit Agricole Mutuel Alpes Provence
PAR:CRAP
|
FR |
|
C
|
CrowdStrike Holdings Inc
LSE:0A3N
|
US |
|
L
|
Las Vegas Sands Corp
DUS:LCR
|
US |
|
Maven Brands Inc
OTC:TRLFF
|
CA |
|
C
|
Ciscom Corp
OTC:CISCF
|
CA |
|
S
|
Sailfish Royalty Corp
XTSX:FISH
|
VG |
|
Cleanaway Co Ltd
TWSE:8422
|
TW |
|
U
|
Umicore SA
OTC:UMICF
|
BE |
|
H
|
Healthpeak Properties Inc
F:HC5
|
US |
|
Budweiser Brewing Company APAC Ltd
HKEX:1876
|
HK |
|
A
|
Alma Gold Inc
OTC:ALGLF
|
CA |
|
E
|
EDP SA
XMUN:EDP
|
PT |
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
Intrinsic Value
Not Available for HRTIS
There is not enough data to reliably calculate the intrinsic value for Herantis Pharma Oyj.
Do our valuations actually work? See backtest results .
Alternatives to HRTIS
Fundamental Analysis
What Herantis Pharma Oyj Does
Herantis Pharma Oyj engages in the research and development of biopharmaceutical products. The company is headquartered in Espoo, Etela-Suomen and currently employs 13 full-time employees. The company went IPO on 2014-06-11. Leveraging research about protein dysregulation for neurodegenerative diseases, and growth stimulation in lymphatic diseases, Herantis develops a pipeline of regenerative biological and gene therapies for high impact diseases.
- Headquarters
- Finland FI
- Employees
- 13
- IPO date
- Jun 11, 2014
Financials
Efficiency
Earnings Waterfall
Herantis Pharma Oyj
Herantis Pharma Oyj
